BioSpace News Archive

Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, presented results from its successful Phase 2 clinical trial of serlopitant for the treatment of pruritis in patients with psoriasis in an oral presentation at the 28th Congress of the European Academy of Dermatology and Venereology held in Madrid yesterday.

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will announce its financial results for the third quarter ended September 31, 2019 and hold its Third Quarter 2019 Earnings Conference Call on Tuesday, November 12, 2019 at 8:30 a.m. EDT

Harbour BioMed (HBM) announced completion of a Phase 2 study in China of HBM9036 (tanfanercept), a new, investigational TNF receptor-1 fragment, in adult patients with moderate-to-severe Dry-Eye-Disease (DED).

Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that three abstracts highlighting clinical and nonclinical data for bardoxolone methyl (bardoxolone) will be presented at the American Society of Nephrology Kidney Week 2019 Annual Meeting being held from November 5 – 10, at the Walter E. Washington Convention Center in Washington, D.C.

Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its third quarter ended September 30, 2019 after the market closes on Thursday, October 24, 2019.

Brio Nutrition, a premium CBD products provider, announced the release of a complete line of health and wellness CBD products that are 100% broad spectrum and hemp-derived with a majority of formulas that are also water soluble.

Chalmers Group of Companies, a privately owned Canadian corporation that manufactures and supplies niche quality equipment to the medical and transportation industries, has announced the acquisition of LYNX Product Group, which designs, develops, and manufactures both standard and custom animal care washing, disinfection, filling, and conveying systems.

AACC is pleased to announce a publishing partnership with Oxford University Press for its peer-reviewed journals, Clinical Chemistry and The Journal of Applied Laboratory Medicine.

SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest article on improving efficiency in pharma manufacturing through IoT technologies.

Palladio Biosciences, Inc. (Palladio) http://palladiobio.com/, a privately-owned, clinical stage biopharmaceutical company developing medicines for orphan diseases of the kidney, announced today the appointment of Marella Thorell as the Company’s Chief Financial Officer.